Jasper Therapeutics Inc (JSPR) — Cash Flow-to-Debt Ratio
Jasper Therapeutics Inc (JSPR) has a Cash Flow-to-Debt Ratio of -0.82x as of March 2026, meaning its operating cash flow of $-14.55 Million could theoretically repay -1% of its total liabilities ($17.78 Million) in one year. Explore JSPR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jasper Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Jasper Therapeutics Inc across 7 annual periods. Also explore Jasper Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jasper Therapeutics Inc (2019–2025)
Year-by-year debt coverage analysis for Jasper Therapeutics Inc. For market capitalisation and broader financial context, see JSPR stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | $-77.16 Million | $31.63 Million | ▲ +29.0% |
| 2024 | -3.43x | $-62.60 Million | $18.23 Million | ▼ -8.5% |
| 2023 | -3.16x | $-52.07 Million | $16.45 Million | ▲ +14.6% |
| 2022 | -3.71x | $-45.86 Million | $12.37 Million | ▼ -165.6% |
| 2021 | -1.40x | $-33.68 Million | $24.14 Million | ▼ -346.8% |
| 2020 | -0.31x | $-18.27 Million | $58.49 Million | ▲ +3.1% |
| 2019 | -0.32x | $-1.97 Million | $6.11 Million | — |